The Special Diabetes Program, a government-funded program dedicated to researching prevention and a cure for diabetes, has just received a two-year extension. In a bipartisan effort, Senators Susan Collins (R-ME) and Jeanne Shaheen (D-NH) led a letter recognizing important contributions of the program and received signatures from 75 Senators and 356 Representatives. The bill allocates $600 million over the two-year period which is crucial to the program as multi-year funding allows for large-scale research and trials.
In previous years, the program has made breakthroughs in artificial pancreas technology and advances in vision improvement for people with diabetic eye disease. “I won’t stop fighting until we have the full scope of resources required to combat this disease,” Senator Shaheen said.
Who benefits from the Special Diabetes Program
The Special Diabetes Program consists of two initiatives: a funding program for type 1 diabetes at the National Institute of Health (NIH) and funding for Special Diabetes Program for Indians (SDPI), which provides treatment, prevention, and education programs for American Indian and Alaska Native populations who are disproportionately affected by type 2 diabetes.
Why the SDP is necessary
Over 100 million Americans live with diabetes or prediabetes, and over a quarter of them are undiagnosed and unaware they have it. This program serves those living with both type 1 and type 2 diabetes by providing research, education, and treatment options.
With 1 in 4 Americans living with this chronic disease, it’s crucial that these life-saving programs continue to receive the funding they need.